Stay on top of the health stories that matter most.
150 articles
Researchers identified the stem cells driving spinal stenosis and found calcium channel blockers may stop ligament overgrowth, potentially sparing.
A study of 95,000 adults links more REM sleep to lower risk of 83 diseases, from dementia to heart failure, suggesting sleep quality matters as much as.
A leaky blood-brain barrier may link depression, bipolar disorder, and schizophrenia, with 80% of supporting research published after 2020.
A new study finds 87% of children show a bidirectional link between screen time and cognitive development, but parental depression shifts that pattern.
Berberine, an ancient plant compound, may slow immune system aging by targeting inflammation, autophagy, and cellular energy all at once.
Psilocybin may prevent chemo nerve pain affecting 60% of patients, while LSD earns FDA fast-track status for depression in a landmark week for psychedelic.
Wisconsin's 988 crisis line prevented 4,400 suicides but faces a $5.2 million annual funding gap because the state lacks a permanent financing mechanism.
Wegovy now comes as a daily pill that costs up to $150 less per month than the shot, though the injection may deliver slightly better weight-loss results.
A genetic variant in TMEM106B raises Alzheimer's TDP-43 risk, potentially explaining why some patients decline faster than others.
Low blood pressure, not high, showed the strongest link to Alzheimer's disease in a study of nearly 800,000 people, complicating what we thought we knew.
Immunotherapy shrinks brain melanoma tumors in roughly half of selected patients, but steroids must be tapered and the brain stabilized before treatment.
GLP-1 weight loss drugs like Ozempic fail up to a third of users; early weight loss in month three predicts success better than any genetic test.
AI chatbots give sleep apnea patients dangerously wrong advice in one-third of cases, reinforcing hesitation to seek care that could lead to serious.
Silicon Valley billionaires are pouring billions into psychedelic medicine, as psilocybin and MDMA near FDA approval for depression and PTSD.
Long-term melatonin use may raise heart failure risk by 90%, prompting sleep doctors to urge insomnia patients to explore safer alternatives.
Delirium after surgery raises the risk of faster cognitive decline by 42%, and experts say up to 40% of cases are preventable with simple care.
The AUA's 2026 bladder cancer guidelines add 40 new recommendations, expanding bladder-preserving options for the 80% of patients diagnosed with.
Insurance coverage mandates boost dense breast supplemental screening nearly four times more than notification laws alone, a study of 12.6 million women.
Nearly 1 in 7 kids has a mental health condition; here are 8 warning signs your child may need a pediatric psychologist.
Strength training has overtaken weight loss as America's top gym goal, with 42% prioritizing muscle, and experts say the shift could transform long-term.
Scientists mapping the brain's cellular landscape are unlocking precision schizophrenia treatment, aiming to end the trial-and-error drug cycle that fails.
Lewy body dementia causes up to 20% of dementia cases yet is routinely misdiagnosed; new skin biopsies and blood tests are finally changing that.
Calcium scans tripled statin adherence versus traditional heart attack risk scores, yet both methods prevented major cardiovascular events at the same.
Hair loss drugs are Wall Street's hottest new bet, with novel treatments targeting 80 million Americans who have had no new approved options since the.
The FDA approved Tudriqev for melanoma patients who've failed immunotherapy, offering a 24.2% response rate where few second-line options existed.
A new study found the keto diet cut liver fat by 67% and reversed prediabetes in half of participants, outperforming Mediterranean and plant-forward diets.
TikTok rosacea advice is wildly inconsistent, and a new study warns that bad tips could make your skin worse; here's how to spot reliable content.
Immunocompromised people face higher COVID infection rates even after vaccination, and the PERSIST study suggests they may need regular, ongoing vaccine.
CAR-T cell therapy fails in over half of responders, but new gene editing and multi-target designs may finally change that for solid tumor patients.
A prison brain injury program cut reoffending rates by 63% and rearrest rates in half, saving millions in criminal justice costs.
A new FDA-approved brain tracer and AI tools can now identify the correct type of dementia with up to 99% accuracy, helping patients get the right.
Pancreatic cancer patients who received nutrition support before surgery completed 82% of chemotherapy versus 50%, with hospital stays cut by three days.
Physical decline starts at 35, but a 50-year Swedish study shows exercise at any age can improve fitness by up to 10 percent.
A normal brain scan after a concussion doesn't mean you're fine; it simply can't detect the functional disruptions causing your headaches, dizziness, and.
Brain injury camps help kids thrive, but CDC layoffs and a lapsed TBI Act have cut federal research funding by 64%, threatening progress for 2.8 million.
Radial's merger with Mindful Health Solutions creates a 27-clinic psychedelic medicine network poised to scale psilocybin and brain treatments as FDA.
The HPV vaccine cuts head and neck cancer risk by 68% in young recipients, new research shows, offering far broader protection than cervical cancer alone.
Leading cardiologists warn a normal ejection fraction can miss heart failure, and 85% of patients had treatable risk factors years before diagnosis.
New insomnia guidelines confirm therapy still beats pills alone, ranking CBT-I above combination treatment for the 20-50% of patients seen in primary care.
One in six Pennsylvania teens has considered suicide, but feeling valued by family cuts that risk by 18%, a major state study finds.
Midlife depression raises Parkinson's disease risk by 36%, and those with genetic vulnerability face more than double the odds, a study of 450,000 people.
Elite athletes get blood clots at alarming rates; Chris Bosh's pulmonary embolism reveals why fitness offers no protection against this deadly condition.
Hidden immune cells called TRMs lurk in the brain beyond MS treatments' reach, potentially explaining why damage continues even when symptoms seem.
A new study found rotavirus vaccine cuts child deaths by 76%, even as the US just made the shot optional rather than a universal recommendation.
A triple-drug combo fully cleared HIV in newborn primates, raising hopes that infants born with HIV could be cured instead of treated for life.
A personalized melanoma vaccine combined with KEYTRUDA cut recurrence risk in a landmark Phase 3 trial, marking the first mRNA cancer therapy to beat.
Wales launched Wim's Protocol to prevent clozapine deaths, after drug interactions raised blood levels by up to 112 percent in schizophrenia patients.
Vision problems after stroke are common yet routinely missed; early screening and rehabilitation can reduce fall risk and help patients regain.
Fewer than 3% of Alzheimer's patients follow all brain health guidelines, even those actively pursuing the latest drug treatments.
Esketamine is the only FDA-approved psychedelic drug, but psilocybin, MDMA, and LSD are all in late-stage trials that could reshape mental health care by.
